Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

NCT05150457 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Solid Tumors

Interventions

DRUG: BNA035

Sponsor

Binacea Pharma, Inc.